Paul Armistead

Paul Armistead serves as a Program Officer responsible for overseeing the planning, solicitation, and management of research and development acquisitions within a federal technical program. In this role, he acts as a critical liaison between scientific stakeholders and procurement teams, ensuring that contract requirements align with mission-critical R&D objectives. He typically handles complex, performance-based solicitations for scientific services, laboratory support, and engineering analysis, often requiring specialized technical expertise and rigorous evaluation criteria. His work directly supports the agency’s mission to advance innovation in physical, engineering, and life sciences through strategic contracting. While no specific contractor relationships are currently identifiable in the data, Armistead’s procurement pattern suggests engagement with a broad spectrum of research institutions, private-sector R&D firms, and academic contractors capable of delivering high-complexity scientific services. He consistently works with vendors possessing advanced technical capabilities in experimental design, data analytics, and prototyping, favoring proposers with proven track records in federally funded research environments. His contracting approach emphasizes technical merit, innovation potential, and compliance with federal research standards over cost alone. Armistead’s procurement portfolio reflects a strong preference for open competition, with 100% of his acquisitions classified as “No Set-Aside.” This indicates a focus on technical excellence and capability rather than socioeconomic preferences, though it does not preclude small business participation where firms demonstrate superior technical qualifications. His approach aligns with mission-driven acquisition strategies that prioritize scientific outcomes over socioeconomic targets. His primary NAICS focus is 541712—Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)—underscoring his specialization in non-biotech scientific innovation. He procures services including experimental physics research, materials testing, computational modeling, and engineering prototyping, often requiring advanced instrumentation and specialized laboratory facilities. His domain expertise lies in supporting foundational scientific discovery through precise, outcome-oriented contracting.